These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30658612)

  • 21. Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer.
    Porcaro AB; De Luyk N; Corsi P; Sebben M; Tafuri A; Processali T; Cerasuolo M; Mattevi D; Cerruto MA; Brunelli M; Siracusano S; Artibani W
    Urol Int; 2017; 99(2):215-221. PubMed ID: 28245478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erectile Function and Oncologic Outcomes Following Open Retropubic and Robot-assisted Radical Prostatectomy: Results from the LAParoscopic Prostatectomy Robot Open Trial.
    Sooriakumaran P; Pini G; Nyberg T; Derogar M; Carlsson S; Stranne J; Bjartell A; Hugosson J; Steineck G; Wiklund PN
    Eur Urol; 2018 Apr; 73(4):618-627. PubMed ID: 28882327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positive Association between Preoperative Total Testosterone Levels and Risk of Positive Surgical Margins by Prostate Cancer: Results in 476 Consecutive Patients Treated Only by Radical Prostatectomy.
    Porcaro AB; Tafuri A; Sebben M; Corsi P; Pocessali T; Pirozzi M; Amigoni N; Rizzetto R; Mariotto A; Inverardi D; Brunelli M; Iacovelli R; Romano M; Siracusano S; Artibani W
    Urol Int; 2018; 101(1):38-46. PubMed ID: 29975957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to optimize patient selection for robot-assisted radical prostatectomy: functional outcome analyses from a tertiary referral center.
    Gandaglia G; Suardi N; Gallina A; Zaffuto E; Cucchiara V; Vizziello D; Shariat S; Cantiello F; Damiano R; Guazzoni G; Montorsi F; Briganti A
    J Endourol; 2014 Jul; 28(7):792-800. PubMed ID: 24660774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive factors for immediate continence after radical prostatectomy.
    Hatiboglu G; Teber D; Tichy D; Pahernik S; Hadaschik B; Nyarangi-Dix J; Hohenfellner M
    World J Urol; 2016 Jan; 34(1):113-20. PubMed ID: 25991601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat prostate biopsies prior to radical prostatectomy do not impact erectile function recovery and mid- to long-term continence.
    Furrer MA; Vilaseca A; Corradi RB; Boxler S; Thalmann GN; Nguyen DP
    Prostate; 2018 Jun; 78(8):631-636. PubMed ID: 29542169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Along the pituitary-testis-prostate axis, serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups.
    Porcaro AB; Petrozziello A; Ghimenton C; Migliorini F; Sava T; Caruso B; Cocco C; Romano M; Artibani W
    Anticancer Res; 2012 Nov; 32(11):5015-22. PubMed ID: 23155273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors of positive surgical margin and biochemical recurrence of patients treated with radical prostatectomy: a single-center 10-year report.
    Li K; Li H; Yang Y; Ian LH; Pun WH; Ho SF
    Chin Med J (Engl); 2011 Apr; 124(7):1001-5. PubMed ID: 21542957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of combined oncologic and functional outcomes after robotic-assisted laparoscopic extraperitoneal radical prostatectomy: trifecta rate of achieving continence, potency and cancer control.
    Xylinas E; Durand X; Ploussard G; Campeggi A; Allory Y; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    Urol Oncol; 2013 Jan; 31(1):99-103. PubMed ID: 21719321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Functional outcomes of transvesical single-site versus extraperitoneal laparoscopic radical prostatectomy for low-risk prostate cancer].
    Liu S; Wen XQ
    Zhonghua Nan Ke Xue; 2014 Nov; 20(11):1012-9. PubMed ID: 25577838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical and oncological outcomes in patients with preoperative PSA >20 ng/ml undergoing robot-assisted radical prostatectomy.
    Zugor V; Witt JH; Heidenreich A; Porres D; Labanaris AP
    Anticancer Res; 2012 May; 32(5):2091-5. PubMed ID: 22593494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomy.
    Hwang EC; Yu SH; Jo YH; Jung SI; Kang TW; Kwon DD; Choi C; Heo SH; Hwang JE; Jung SH; Jung TY
    Asian J Androl; 2016; 18(1):54-9. PubMed ID: 25966628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity and hypogonadism are associated with an increased risk of predominant Gleason 4 pattern on radical prostatectomy specimen.
    Neuzillet Y; Raynaud JP; Lebret T; Pichon A; Radulescu C; Molinie V; Botto H
    Horm Mol Biol Clin Investig; 2015 Jun; 22(3):101-9. PubMed ID: 26047422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer.
    Dai B; Qu Y; Kong Y; Ye D; Yao X; Zhang S; Wang C; Zhang H; Yang W
    BJU Int; 2012 Dec; 110(11 Pt B):E667-72. PubMed ID: 22974446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Minimally invasive radical prostatectomy: transition from pure laparoscopic to robotic-assisted radical prostatectomy.
    Trabulsi EJ; Zola JC; Colon-Herdman A; Heckman JE; Gomella LG; Lallas CD
    Arch Esp Urol; 2011 Oct; 64(8):823-9. PubMed ID: 22052763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy.
    Salonia A; Gallina A; Abdollah F; Briganti A; Capitanio U; Suardi N; Ferrari M; Raber M; Colombo R; Freschi M; Rigatti P; Montorsi F
    World J Urol; 2012 Aug; 30(4):533-9. PubMed ID: 21935733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
    Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
    J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Müllerian hormone: a novel biomarker for aggressive prostate cancer? Emerging evidence from a prospective study of radical prostatectomies.
    Kontogiannis S; Markantes G; Stamou M; Tsagkarakis M; Mamali I; Giannitsas K; Perimenis P; Georgopoulos N; Athanasopoulos A
    Hormones (Athens); 2024 Jun; 23(2):297-304. PubMed ID: 38127275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
    Glickman L; Godoy G; Lepor H
    J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline.
    Pompe RS; Karakiewicz PI; Tian Z; Mandel P; Steuber T; Schlomm T; Salomon G; Graefen M; Huland H; Tilki D
    J Urol; 2017 Aug; 198(2):354-361. PubMed ID: 28216329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.